Evidence map›Paper›PMID 36364013›Full record

ReviewMolecules (Basel, Switzerland)2022

Sources, Transformations, Syntheses, and Bioactivities of Monoterpene Pyridine Alkaloids and Cyclopenta[c]pyridine Derivatives.

Xuejian Zhang, Feiyan Tao, Tao Cui, Cheng Luo, Zhigang Zhou, Yuchuan Huang, Lanlan Tan, Wei Peng, Chunjie Wu

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. MarineMarine drugs · 2024
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xuejian ZhangResearch and Development Centre, China Tobacco Sichuan Industrial Co., Ltd., Chengdu 610066, China.
Feiyan TaoResearch and Development Centre, China Tobacco Sichuan Industrial Co., Ltd., Chengdu 610066, China.
Tao CuiResearch and Development Centre, China Tobacco Sichuan Industrial Co., Ltd., Chengdu 610066, China.
Cheng LuoResearch and Development Centre, China Tobacco Sichuan Industrial Co., Ltd., Chengdu 610066, China.
Zhigang ZhouResearch and Development Centre, China Tobacco Sichuan Industrial Co., Ltd., Chengdu 610066, China.
Yuchuan HuangResearch and Development Centre, China Tobacco Sichuan Industrial Co., Ltd., Chengdu 610066, China.
Lanlan TanResearch and Development Centre, China Tobacco Sichuan Industrial Co., Ltd., Chengdu 610066, China.
Wei PengSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0003-0511-9564
Chunjie WuSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
China Tobacco · CNChengdu University of Traditional Chinese Medicine · CN

Funding

Sichuan Basic Research Program 2018JY0599
6 · The paper itself

Abstract

Monoterpene pyridine alkaloids (MTPAs) are alkaloids derived from iridoid glycosides (IGs). The common molecular structure of MTPAs is the pyridine ring, while some of them have a cyclopenta[c]pyridine skeleton. Some compounds containing this structure are potentially bioactive medicinal agents. In this paper, seven drug candidates (

Indexed as

AlkaloidsBiological ProductsMolecular StructureMonoterpenesPyridinesAlkaloidsBiological ProductsMonoterpenesPyridinesbioactivitycyclopenta[c]pyridine derivativesmonoterpene pyridine alkaloidssourcesynthesistransformation

Identifiers

PMID36364013
PMCPMC9656638
OpenAlexW4307270122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.